LSN3318839
Based on 1 Customer Validation
LSN3318839 is an orally active positive modulator of the glucagon-like peptide-1 receptor (GLP-1R). LSN3318839 can increase the secretion of insulin and has the effect of lowering blood sugar.
For research use only. We do not sell to patients.
- Purity: 99.22%
- CAS No.: 2764704-18-7
- Formula: C26H23Cl2N3O2
- Molecular Weight:480.39
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
LSN3318839 (0-19 μM) enhances the potency and efficacy of GLP-1(9-36) in GLP-1R-expressed HEK293 cells, but does not affect the potency of GLP1(7-36)[1].
LSN3318839 (1-3 μM) significantly increases insulin secretion in combination with GLP-1 (9-36) in INS-1 832-3 cells with high glucose presence[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Pharmacokinetic Analysis in mice, rats and dogs[1]
Pharmacokinetic Analysis[1]
| Species | Route | Dose (mg/kg) | AUC (nM×hour) | Cmax (nM) | T1/2 (h) | Vdss (L/kg) | Cl (mL/min/kg) | Tmax (h) | % F |
| mouse | i.v. | 1 | 3640 | 1430 | 2.1 | 1.6 | 9.0 | / | / |
| mouse | p.o. | 3 | 7300 | 2040 | 1.6 | / | / | 0.58 | 67 |
| rat | i.v. | 1 | 859 | 1420 | 0.6 | 1.6 | 41.9 | / | / |
| rat | p.o. | 3 | 1160 | 183 | 2.9 | / | / | 1.8 | 45 |
| dog | i.v. | 1 | 1880 | 6780 | 0.6 | 0.3 | 18.5 | / | / |